Onconetix, Inc. Increase (Decrease) in Derivative Liabilities
Onconetix, Inc. (ONCO) reported Increase (Decrease) in Derivative Liabilities of $99.79 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2023-11-17
- Onconetix, Inc. increase (decrease) in derivative liabilities for the quarter ending 2023-09-30 was $99.73K.
- Onconetix, Inc. increase (decrease) in derivative liabilities for the quarter ending 2023-06-30 was $1.67K.
- Onconetix, Inc. increase (decrease) in derivative liabilities for the quarter ending 2023-03-31 was -$1.61K.
- Onconetix, Inc. increase (decrease) in derivative liabilities for the quarter ending 2022-12-31 was -$28.04K.
- Onconetix, Inc. increase (decrease) in derivative liabilities for fiscal 2022 was -$61.41K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2023-09-30 | $99.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $101.40K derived: sum of 2 quarters · filed 2023-11-17 | $99.79K 10-Q · filed 2023-11-17 | $71.75K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | $1.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $59.00 10-Q · filed 2023-10-20 | -$27.98K derived: sum of 3 quarters · filed 2023-10-20 | -$31.05K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | -$1.61K 10-Q · filed 2023-05-12 | -$29.65K derived: sum of 2 quarters · filed 2023-05-12 | -$32.72K derived: sum of 3 quarters · filed 2023-11-17 | |
| 2022-12-31 | -$28.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$31.11K derived: sum of 2 quarters · filed 2023-11-17 | -$61.41K 10-K · filed 2023-03-09 | |
| 2022-09-30 | -$3.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | -$33.38K 10-Q · filed 2023-11-17 | ||
| 2022-06-30 | -$30.30K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |